Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Gross Profit: 2013-2023

Historic Gross Profit for RedHill Biopharma (RDHL) over the last 5 years, with Jun 2023 value amounting to $990,000.

  • RedHill Biopharma's Gross Profit fell 89.41% to $990,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $15.3 million, marking a year-over-year decrease of 51.16%. This contributed to the annual value of $4.9 million for FY2024, which is 57.96% up from last year.
  • RedHill Biopharma's Gross Profit amounted to $990,000 in Q2 2023, which was down 50.18% from $2.0 million recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Gross Profit registered a high of $12.4 million during Q3 2021, and its lowest value of -$659,000 during Q1 2020.
  • Moreover, its 3-year median value for Gross Profit was $7.5 million (2022), whereas its average is $6.8 million.
  • Per our database at Business Quant, RedHill Biopharma's Gross Profit plummeted by 149.92% in 2020 and then soared by 1,666.31% in 2021.
  • RedHill Biopharma's Gross Profit (Quarterly) stood at $802,000 in 2019, then spiked by 1,247.76% to $10.8 million in 2020, then crashed by 74.68% to $2.7 million in 2021, then spiked by 53.45% to $4.2 million in 2022, then tumbled by 89.41% to $990,000 in 2023.
  • Its last three reported values are $990,000 in Q2 2023, $2.0 million for Q1 2023, and $4.2 million during Q4 2022.